The Steven Coutre Review of the 65th Annual American Society of Hematology Meeting

The 2024 Steven Coutre Review of the 65th ASH (American Society of Hematology) Meeting is a highly anticipated event that will showcase the latest research and data on hematologic disorders. The review aims to provide healthcare professionals with updated treatment algorithms and strategies that are geared towards optimizing the care of their patients. This comprehensive review is designed to provide up-to-date and practical information to healthcare professionals who are dedicated to improving the care of their patients with hematologic disorders. By attending the Steven Coutre Review, participants will gain new insights and knowledge that can be applied to their clinical practice, ultimately leading to better patient outcomes. The conference will utilize a variety of learning modalities, including case studies, panel discussions, and audience response questions, to foster meaningful interactions between expert faculty presenters and symposium participants. The case studies will allow healthcare professionals to delve deep into real-life patient scenarios and learn from the experiences of their colleagues. Panel discussions will offer a platform for experts in the field to share their knowledge and insights on the latest research and advancements in hematology. Audience response questions will provide a chance for symposium participants to test their knowledge and understanding of the presented material.

Registration fee includes course materials, certificate of participation, breakfast and lunch. Parking is not included in the registration fee. 

Registration Fees: (Before 1/10/2024)
Physicians: $195
Nurses & Allied Health Professionals: $195
Industry: Full (Waitlist closed)
Stanford Fellows/Residents/AHPs in Training: Free, please email [email protected] for code to register

Registration Fees: (After 1/10/2024)
Physicians: $245
Nurses & Allied Health Professionals: $245
Stanford Fellows/Residents/AHPs in Training: Free, please email [email protected] for code to register

Register online with Visa or Master Card.  If you prefer to pay by check or need assistance, email [email protected].

Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently.  

Parking: A daily valet parking fee of $30.00 per car for weekdays, and $50.00 per car for weekends. 

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator. 

1. Evaluate the use of new chemotherapeutics and biologics in subpopulations of acute myeloid leukemia patients based on patient clinical and genetic profiles
2. Review new drug approvals and practical considerations for their safe and optimal use
3. Use case-based discussions to evaluate the role of new therapies in non-malignant hematology indications
4. Evaluate optimal sequencing and combinations of novel agents for lymphoid and myeloid malignancies
5. Incorporate the most recent data on myeloid precursor states, available monitoring and therapies.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MOC Participation Threshold
Learner completes answers to a quiz, percent of correct answers required will be set by provider.

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Robert Schramm
     Event Coordinator
     [email protected]
     

For CME general questions, please contact 
     Email: [email protected]

Conference Location and Accommodations

The Ritz-Carlton, Half Moon Bay
1 Miramontes Point Road
Half Moon Bay, California 94019 
(650) 712-7000

A block of rooms has been reserved at a reduced rate at The Ritz-Carlton, Half Moon Bay, for conference participants on a first-come, first-served basis and may sell out before 01/10/2024. After this date, reservations will be accepted on a space available basis and the group rate will no longer be guaranteed. To make your reservation, please call 1-888-293-0524.

Room Standard
Rate $495.00*
*Plus 15% Occupancy tax, $5.50 in state, local and tourism fee, 9.375% local sales tax, and $60.00/day resort fee. A daily valet parking fee of $30.00 per car for weekdays, and $50.00 per car for weekends.  Overnight valet parking is $65.00 per car, per night. These taxes are not included in the room rate and are subject to change without notice.

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

William Shomali, MD
Clinical Assistant Professor, Hematology
Stanford University

Co-Course Director and Reviewer, Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte|Grant or research support-Incyte|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blueprint Medicine (Relationship has ended)|Grant or research support-Blueprint Medicines

Tian Zhang, MD
Assistant Professor of Medicine, Hematology
Stanford University

Co-Course Director and Reviewer, Faculty

Nothing to disclose

Ranjana Advani, MD
Saul A. Rosenberg, Professor of Lymphoma, Oncology
SHC - Cancer Center

Faculty

Advisor-Bristol-Myers Squib Aventis (Relationship has ended)|Grant or research support-BeiGene|Advisor-BeiGene|Advisor-Incyte (Relationship has ended)|Advisor-Epizyme (Relationship has ended)|Grant or research support-Regeneron (Relationship has ended)|Grant or research support-Seattle Genetics|Advisor-Regeneron (Relationship has ended)|Grant or research support-Seattle Genetics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi-Aventis (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi-Aventis (Relationship has ended)|Advisor-ADC Therapuetics|Advisor-Roche|Grant or research support-Roche|Grant or research support-Merck and Company, Inc.|Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-Daiichi Sankyo (Relationship has ended)|Grant or research support-Daiichi Sankyo|Grant or research support-Cyteir|Grant or research support-Congupro|Advisor-Autolus Limited

Caroline Berube, MD
Clinical Assoiate Professor of Medicine, HematologyMedical Director, Oral Anticoagulation Clinic
SHC

Faculty

Grant or research support-Pfizer, Inc.|Consulting Fee-Genentech, Inc. (Relationship has ended)

Rondeep Singh Brar, MD
Clinical Associate Professor
Stanford Hospital & Clinics

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Apellis Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alexion Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis AG

May Chien, MD
Clinical Assistant Professor of Medicine, Hematology
Clinical Assistant Professor of Pediatrics Hematology/Oncology
Division of Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine
Stanford University School of Medicine

Faculty

Nothing to disclose

Robert Diep, MD
Clinical Assistant Professor, Hematology
SHC - Cancer Center

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sobi (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Shield Therapeutics (Relationship has ended)

Bita Fakhri, MD
Assistant Professor of Medicine, Hematology
Stanford University

Faculty

Advisor-Bristol-Myers Squibb (Relationship has ended)|Grant or research support-Bristol-Myers Squibb (Relationship has ended)|Advisor-Eli Lilly and Company (Relationship has ended)|Speakers Bureau-Eli Lilly and Company|Advisor-Johnson and Johnson (Relationship has ended)|Advisor-Pharmacyclics, Inc. (Relationship has ended)

Sebastian Fernandez-Pol, MD
Clinical Assistant Professor, Pathology
Stanford University

Faculty

Honoraria-Leica Biosystems|Consulting Fee-Cartography Biosciences

Matthew Joshua Frank, MD, PhD
Assistant Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine

Faculty

Nothing to disclose

Jason Gotlib, MD

Faculty

Grant or research support-Incyte|Grant or research support-Novartis AG (Relationship has ended)|Grant or research support-Kartos (Relationship has ended)|Grant or research support-Blueprint Medicines|Grant or research support-Deciphera (Relationship has ended)|Grant or research support-Cogent Biosciences|Grant or research support-Abbvie|Grant or research support-Bristol-Myers Squibb|Grant or research support-Protagonist Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis AG (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Kartos (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blueprint Medicines|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Deciphera (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cogent Biosciences|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Abbvie (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Protagonist Therapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-PharmaEssentia (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Imago Biosciences (Relationship has ended)

Peter Greenberg, MD
Professor of Medicine
Stanford University Cancer Center
Us

Faculty

Grant or research support-Gilead|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Fibrogen (Relationship has ended)|Grant or research support-Aprea|Grant or research support-Notable Labs

Ruwan Gunaratne, MD, PhD
Hematology/Oncology Fellow
Stanford University

Faculty

Nothing to disclose

David Iberri, MD
Assistant Professor of Medicine (Hematology)
SHC - Cancer Center

Faculty

Nothing to disclose

Lawrence Leung, MD
Maureen Lyles D'Ambrogio Professor in the School of Medicine, Hematology
Stanford University

Faculty

Nothing to disclose

Michaela Liedtke, MD
Associate Professor of Medicine (Hematology)
Stanford University School of Medicine

Faculty

Advisor-Adaptive (Relationship has ended)|Advisor-Abbvie (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Advisor-Nexcella|Advisor-Kite (Relationship has ended)|Advisor-Bristol-Myers Squib Aventis (Relationship has ended)

James Mathew Malone, MD
Clinical Associate Professor of Medicine
Stanford University

Faculty

Nothing to disclose

Gabriel Mannis, MD
Associate Professor of Medicine (Hematology)
Stanford University School of Medicine

Faculty

Advisor-Astellas|Advisor-BMS/Celgene (Relationship has ended)|Advisor-Abbvie|Advisor-Genentech|Consulting Fee-Macrogenics|Advisor-Servier (Relationship has ended)|Advisor-Stemline (Relationship has ended)|Grant or research support-Glycomimetics|Grant or research support-Gilead|Grant or research support-Astex|Grant or research support-Syndax|Grant or research support-ImmuneOnc|Grant or research support-ImmunoGen|Advisor-Orbital Therapeutics|Advisor-Rigel|Advisor-Wugen (Relationship has ended)|Advisor-Immunogen (Relationship has ended)|Advisor-Syndax (Relationship has ended)|Grant or research support-Aptose|Grant or research support-Bristol-Myers Squibb

Beth A. Martin, MD
Clinical Associate Professor, Medicine - Hematology
Stanford University School of Medicine

Faculty

Nothing to disclose

Jean Soonmyong Oak, MD, PhD
faculty
Stanford University

Faculty

Nothing to disclose

Rebecca Rojansky, MD, PhD
Stanford University

Faculty

Nothing to disclose

Ghazal Salmasi, MD
Clinical Associate Professor, Medicine, Hematology
Stanford University

Faculty

Nothing to disclose

Fangdi Sun, MD
Stanford University

Faculty

Nothing to disclose

Alejandro Villar-Prados, MD, PhD
Stanford

Faculty

Nothing to disclose

Jared Wallace, MD, PhD
Fellow
Stanford Health Care

Faculty

Nothing to disclose

James Zehnder, MD
Professor of Medicine, Pathology, Hematology
Stanford University

Faculty

Nothing to disclose

Saturday, February 10, 2024

This CME Activity is supported in part by educational grants from AstraZeneca and Eli Lilly and Company.